Skip to content

Glycemic and insulinemic response after oral ingestion of HBF2020-04

Glycemic and insulinemic response after oral ingestion of HBF2020-04 - Glycemic and insulinemic response after oral ingestion of HBF2020-04

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042533
Enrollment
20
Registered
2020-11-25
Start date
2020-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanease adults

Interventions

Oral ingestion of the test food HBF2020-04 Oral ingestion of glucose

Sponsors

Oneness Support Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1] Healthy males and females aged 20-65 years old when informed consent. [2] [3] Individuals giving written informed consent

Exclusion criteria

Exclusion criteria: [1] Who have a disease and/or surgical history of serious hepatopathy, kidney damage, gastrointestinal disease, heart disease, peripheral vascular disorder, others which may affect the results of the study. [2] Who with liver disorder, and/or kidney disorder. [5] who are under medical treatments. [6] Who are allergic to foods and/or medicines. [7] Who are diagnosed as anemia. [8] Who play intense sports and/or on a diet. [10] Who use supplements which may affect the results of the study. [11] Who take medicines. [12] Who daily take excessive alcohol, and/or can't abstinent from alcohol from the day before the each examinations. [13] Who are or are possibly pregnant, or who are lactating, during the study period. [14] Who are participating or are willing to participate in other studies. [15] Who are judged inappropriate for the study by the investigator

Design outcomes

Primary

MeasureTime frame
Blood glucose and insulin level at 15, 30, 45, 60, 90, 120 min after ingestion

Secondary

MeasureTime frame
Physical examination, and medical examination by hematology, blood biochemistry, urinalysis

Countries

Japan

Contacts

Public ContactAkiko Mizote

Hayashibara CO., LTD. R & D Division, Development Unit

akiko.mizote@hb.nagase.co.jp086-276-3141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026